Rabih Halabi, MD
Pulmonary Disease · Falls Church, VANPI 1598972861
Payments from drug & device makers
Across 784 payments — averaging $770.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$340K
- Regeneron Healthcare Solutions, Inc.$242K
- Genentech USA, Inc.$7K
- Regeneron$4K
- EMD Serono, Inc.$4K
- AstraZeneca$3K
- plus $5K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 278 | $340,168 |
| Regeneron Healthcare Solutions, Inc. | 300 | $242,299 |
| Genentech USA, Inc. | 26 | $6,690 |
| Regeneron | 2 | $3,672 |
| EMD Serono, Inc. | 1 | $3,570 |
| AstraZeneca | 36 | $2,755 |
| Insmed, Inc. | 8 | $1,520 |
| GSK | 54 | $1,214 |
| Sanofi-aventis U.S. LLC | 4 | $284 |
| Baxter Healthcare | 9 | $238 |
| Boehringer Ingelheim | 12 | $236 |
| Pulmonx Corporation | 2 | $187 |
| Verona Pharma, Inc. | 3 | $178 |
| Amgen | 7 | $166 |
| Mylan Specialty L.p. | 7 | $144 |
| Johnson & Johnson | 5 | $94 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $79 |
| Novartis | 4 | $76 |
| Viatris Specialty LLC | 1 | $59 |
| Grifols USA, LLC | 2 | $51 |
| United Therapeutics Corporation | 2 | $49 |
| Bayer | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| Philips North America LLC | 2 | $32 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Merck | 2 | $29 |
| Shionogi Inc | 1 | $27 |
| Pfizer | 2 | $27 |
| Actelion Pharmaceuticals US, Inc. | 2 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Medical Graphics Corporation | 1 | $19 |
| Electromed, Inc. | 1 | $16 |
| Gilead | 1 | $16 |
How this compares
$604,069 in reported general payments places this provider in the 95th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Falls Church
- Steven NathanFalls Church$2.5M
- Shambhu AryalFalls Church$115K
- Anne BrownFalls Church$76K
- Vikramjit KhangooraFalls Church$71K
- Jared WilkinsonFalls Church$19K
- Shilpa JohriRichmond$1.7M
- Omar MinaiHopewell$1.3M
- Vijay SubramaniamWilliamsburg$1.3M
- Patricia SimeRichmond$572K
- Apostolos PerelasRichmond$567K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.